Equity Details
Price & Market Data
Price: $9.90
Daily Change: -$1.01 / 10.20%
Daily Range: $9.54 - $11.50
Market Cap: $535,972,384
Daily Volume: 402,257
Performance Metrics
1 Week: -16.27%
1 Month: 1.96%
3 Months: -23.33%
6 Months: -36.01%
1 Year: -36.01%
YTD: -36.01%
About Eikon Therapeutics, Inc. (EIKN)
Financial summary for Eikon Therapeutics, Inc. (EIKN). Price: 9.90, daily change: -$1.01 / 10.20%. Market cap: 535,972,384. Performance for all periods at a glance.
Details
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.
